Regional Strategic Plan for Immunization 2014–2020
To provide universal immunization coverage within the WHO African Region by 2020.
- To improve immunization coverage beyond the current levels.
- To complete interruption of poliovirus transmission and ensure virus containment.
- To attain the elimination of measles and make progress in the elimination of rubella and congenital rubella syndrome.
- To attain and maintain elimination/control of other vaccine-preventable diseases.
Objective 1: To improve immunization coverage beyond the current levels
- DTP3 vaccine coverage to reach 90% region-wide by the end of 2020
- All countries to introduce PCV by the end of 2020
- At least 37 countries to introduce the rotavirus vaccine by 2020
- At least 35 countries to introduce HPV by the end of 2020
- At least 25 countries to introduce a birth dose of hepatitis B vaccine by the end of 2020
- All countries to regularly report adverse events following immunization by the end of 2020
Objective 2: To complete interruption of poliovirus transmission and ensure virus containment
- All countries to interrupt transmission of wild poliovirus by 2014
- All OPV-using countries to introduce at least one dose of inactivated polio vaccine by 2015
- All polioviruses to be laboratory contained and the Region certified polio free by the end of 2018
- A regional polio legacy plan to be finalized by the end of 2015
Objective 3: To attain the elimination of measles and make progress in the elimination of rubella and congenital rubella syndrome
- All countries to achieve an incidence of confirmed measles of less than 1 case per million population by 2020
- MCV1 coverage to be at least 95% at the national and district levels and SIA coverage to be 95% in all districts
- At least 25 countries to introduce rubella-containing vaccine by 2020
Objective 4: To attain and maintain elimination/control of other vaccine-preventable diseases
- All countries to attain and validate elimination of maternal and neonatal tetanus by 2020
- All high-risk countries to attain yellow fever immunization coverage of 90% or higher by 2020
- All countries within the meningitis belt to introduce MenAfriVac through campaigns, and 15 of them to have the vaccine in routine immunization by 2020
- Seroprevalence of HbsAg among children younger than 5 years to be less than 2% by 2020
ga('create', 'UA-101501857-1', 'auto');